title: [Are non-invasive tests going to replace liver biopsy for diagnosis of liver fibrosis?].
abstract: Liver fibrosis is associated with chronic liver diseases, and may evolve into cirrhosis that may be complicated by liver failure and portal hypertension. Detection and quantification of liver fibrosis is a key point in the follow-up of patients with chronic liver diseases. Liver biopsy is the gold standard method to assess and quantify fibrosis, but its invasiveness is a limiting factor in everyday clinical practice. Non invasive markers using either biological or radiological parameters have been developed and may decrease the need for liver biopsy in some cases. However, information is limited to fibrosis, and cut-offs values and diagnostic accuracies for significant fibrosis may vary according to the etiology of liver disease. Liver biopsy allows the assessment of intermediate stages of fibrosis and describes accompanying lesions.
authors.affiliation: Service de médecine interne générale Département de médecine interne, rehabilitation et gériatrie HUG, Geneve. sophie.restellini@hcuge.ch
authors.forename: Sophie
authors.initials: S
authors.lastname: Restellini
authors.forename: Laurent
authors.initials: L
authors.lastname: Spahr
mesh_terms: D015415:Biomarkers / Q000097:blood; D044963:Biopsy, Fine-Needle; D054459:Elasticity Imaging Techniques / Q000379:methods*; D006801:Humans; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000175:diagnosis*
chemical_list: D015415:Biomarkers